Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3174772rdf:typepubmed:Citationlld:pubmed
pubmed-article:3174772lifeskim:mentionsumls-concept:C0028040lld:lifeskim
pubmed-article:3174772lifeskim:mentionsumls-concept:C0006948lld:lifeskim
pubmed-article:3174772lifeskim:mentionsumls-concept:C0014898lld:lifeskim
pubmed-article:3174772lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:3174772lifeskim:mentionsumls-concept:C0682770lld:lifeskim
pubmed-article:3174772pubmed:issue2lld:pubmed
pubmed-article:3174772pubmed:dateCreated1988-11-1lld:pubmed
pubmed-article:3174772pubmed:abstractTextA number of aromatic, cycloalkyl, and heterocyclic carbamic acid esters, thiocarbamic acid esters, and carboxylic acid esters of di- and trial-kylaminoalkyl and heterocyclic amino alcohols have been synthesized and tested for their pharmacologic and receptor binding characteristics at the nicotine receptor. Receptor binding was measured in rat brain membranes using (-)-3H-nicotine or 3H-methylcarbamylcholine as radioligands. The compounds were tested for their ability to produce seizures and prostration and to antagonize the nicotine-induced prostration and seizures as well as the hypertensive action of nicotine in rats. Among the potent agonists were the N-methylcarbamyl and N-methylthiocarbamyl esters of choline (trimethylaminoethanol), with the tertiary amino derivatives between considerably less potent than the quaternary. Potent antagonists included trimethylaminoethyl benzoate, 3-quinuclidinyl benzoate, and trimethylaminoethyl esters of phenyl and phenylthiocarbamic acids. One of the most potent antagonists to nicotine was alpha-lobeline.lld:pubmed
pubmed-article:3174772pubmed:languageenglld:pubmed
pubmed-article:3174772pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3174772pubmed:citationSubsetIMlld:pubmed
pubmed-article:3174772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3174772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3174772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3174772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3174772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3174772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3174772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3174772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3174772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3174772pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3174772pubmed:statusMEDLINElld:pubmed
pubmed-article:3174772pubmed:monthJunlld:pubmed
pubmed-article:3174772pubmed:issn0091-3057lld:pubmed
pubmed-article:3174772pubmed:authorpubmed-author:AboodL GLGlld:pubmed
pubmed-article:3174772pubmed:authorpubmed-author:MaitiAAlld:pubmed
pubmed-article:3174772pubmed:authorpubmed-author:Shahid...lld:pubmed
pubmed-article:3174772pubmed:issnTypePrintlld:pubmed
pubmed-article:3174772pubmed:volume30lld:pubmed
pubmed-article:3174772pubmed:ownerNLMlld:pubmed
pubmed-article:3174772pubmed:authorsCompleteYlld:pubmed
pubmed-article:3174772pubmed:pagination403-8lld:pubmed
pubmed-article:3174772pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:meshHeadingpubmed-meshheading:3174772-...lld:pubmed
pubmed-article:3174772pubmed:year1988lld:pubmed
pubmed-article:3174772pubmed:articleTitleStructure-activity studies of carbamate and other esters: agonists and antagonists to nicotine.lld:pubmed
pubmed-article:3174772pubmed:affiliationDepartment of Pharmacology, University of Rochester, School of Medicine and Dentistry, NY 14642.lld:pubmed
pubmed-article:3174772pubmed:publicationTypeJournal Articlelld:pubmed